The Influence of Experimentally Induced Osteoarthrosis on Articular Nerve Fibers of the Sheep Temporomandibular Joint

Aims: To study the effect of experimentally induced osteoarthrosis, or non-inflammatory degenerative changes, on the innervation of the sheep temporomandibular joint (TMJ) through the use of indirect immunohistochemistry and image analysis quantification. Methods: Bilateral condylar scarification was performed in8 sheep, which were killed at 16 weeks post-operation; 3 unoperated sheep served as controls. Tissues from 8 osteoarthrotic joints and 4 control joints were processedfor the immunostaining with antisera for protein gene product 9.5 (PGP 9.5), substance P (SP), calcitonin gene-related peptide (CGRP), neuropeptide Y (NPY), vasoactive intestinal peptide (VIP), and tyrosine hydroxylase (TH). An additional 10 joints were decalcified to study the morphologic changes induced by the condylar abrasion. Results: Osteoarthrotic changes were commonly seen in the anterior and lateral regions of the joint and included fibrosis, peripheral osteophyteformation, cysts, and erosion of articular surfaces. In the osteoarthrotic joints, the distribution of PGP 9.5-, CGRP-, and SP-immunoreactive (IR) nerve fibers was similar to that observed for control joints in the capsule, synovium, and capsule/disc junction. There were statistically detectable decreases in the percent surface area of IR nerve fibers in the capsule for both PGP 9.5 and CGRP in arthrotic joints compared with control joints. The lateral and anterior regions of the capsule had greater density of PGP 9.5- and CGRP-IR nerve fibers than other parts of the capsule in both control and arthrotic joints, and the medial capsule was poorly innervated in all joints. Immunostaining for substance P was always weaker. Conclusion: This study suggests that while inflammatory arthritis has a marked influence on the density of sensory and autonomic nerve fibers in synovium in a variety of joints in different species, experimentally induced non-inflammatory osteoarthrosis in the sheep TMJ also leads to a depletion of the density of nerve fibers in the capsule, especially in the lateral part of the joint. Further work is required to determine whether other parts of the joint, such as synoviumand marrow, respond differently to experimentally induced osteoarthrosis.

calcitonin gene-related peptide; substance P; protein gene product 9.5; neuropeptide Y; nerve fibers; temporomandibular joint; osteoarthrosis

1. Grönblad DM, Konttinen YT, Korkala O, Liesi P, Hukkanen M, Polak JM. Neuropeptides in synovium of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 1988;15:1807–1810.

2. Konttinen YT, Rees R, Hukkanen M, et al. Nerves in inflammatory synovium: Immunohistochemical observations on the adjuvant rat model. J Rheumatol 1990;17:1586–1591.

3. Mapp PI, Kidd BL, Gibson SJ, et al. Substance P-, calcitonin gene-related peptide- and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience 1990;37:143–153.

4. Hukkanen M, Grönblad M, Rees R, et al. Regional distribution of mast cells and peptide-containing nerves in normal and adjuvant arthritic rat synovium. J Rheumatol 1991;18:177–183.

5. Buma P, Verschuren C, Versleyen D, Van der Kraan P, Oestreicher AB. Calcitonin gene-related peptide, substance P and GAP-43/B-50 immunoreactivity in the normal and arthrotic knee joint of the mouse. Histochemistry 1992;98:327–339.

6. Goss AN, Kurita K, McMahon L. The Sheep as a Model for Temporomandibular Joint Disorders. Adelaide: University of Adelaide, Department of Dentistry, 1995.

7. Bosanquet AG, Goss AN. The sheep as a model for temporomandibular joint surgery. Int J Oral Maxillofac Surg 1987;16:600–603.

8. Ishimaru J-I, Goss AN. A model for osteoarthritis of the temporomandibular joint. J Oral Maxillofac Surg 1992;50:1191–1195.

9. Tahmasebi-Sarvestani A, Tedman RA, Goss AN. Neural structures within the sheep temporomandibular joint. J Orofac Pain 1996;10:217–231.

10. Tahmasebi-Sarvestani A, Tedman RA, Goss AN. Distribution and coexistence of neuropeptides in nerve fibres in the temporomandibular joint of late gestation fetal sheep. J Anat 1997;191:245–257.

11. Coons AH, Ledue EH, Connolly JM. Studies on antibody production. A method for the histochemical demonstration of specific antibody and its application to a study of the lymph-immune rabbit. J Exp Med 1955;102:49–63.

12. Gibbins IL. Target-related patterns of co-existence of neuropeptide and vasoactive intestinal peptide, enkephalin and substance P in cranial parasympathetic neurons innervating the facial skin and exocrine glands of guinea-pigs. Neuroscience 1990;38:541–560.

13. Gibbins IL. Vasoconstrictor, vasodilator and pilomotor pathways in sympathetic ganglia of guinea-pigs. Neuroscience 1992;47:657–672.

14. Gibbins IL, Matthew SE. Dendritic morphology of presumptive vasoconstrictor and pilomotor neurons and their relations with neuropeptide containing preganglionic fibres in lumbar sympathetic ganglia of guinea pigs. Neuroscience 1996;70:998–1012.

15. Ishimaru J-I, Kurita K, Handa Y, Goss AN. Temporomandibular joint osteoarthritis: Literature review and experimental animal models. Hosp Dent (Tokyo) 1991;3:64–68.

16. Silberman M. Experimentally induced osteoarthrosis in the temporomandibular joint of the mouse. Acta Anat (Basel) 1976;96:9–24.

17. Merjersjo C, Kopp S. Long term development after treatment of mandibular dysfunction and osteoarthrosis. A clinical-radiographic follow up and an animal experimental study. Swed Dent J 1984;22:1–10.

18. Yaillen DM, Shapiro PA, Luschei ES, Feldman GR. Temporomandibular joint meniscectomy—Effect on joint structure and masticatory function in Macaca fascicularis. J Oral Maxillofac Surg 1979;7:255–230.

19. Helmy ES, Bays RA, Sharawy M. Osteoarthrosis of the temporomandibular joint following experimental disc perforation in Macaca fascicularis. J Oral Maxillofac Surg 1988;46:979–990.

20. Blackwood HJ. Arthritis of the mandibular joint. Br Dent J 1962;115:317–326.

21. Ogus H. Rheumatoid arthritis of the temporomandibular joint. Br J Oral Surg 1975;12:275–284.

22. Kreutziger KL, Mahan PE. Temporomandibular degenerative joint disease. Part 1. Anatomy, pathophysiology and clinical description. Oral Surg Oral Med Oral Pathol 1975;40:165–182.

23. Appelgren A, Appelgren B, Eriksson S, et al. Neuropeptides in temporomandibular joint with rheumatoid arthritis. A clinicalstudy. Scand J Dent Res 1991;99:519–521.

24. Holmlund A, Ekblom A, Hansson P, Lind J, Lundeberg T, Theodorsson E. Concentrations of neuropeptides substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid of the human temporomandibular joint. Int J Oral Maxillofac Surg 1991;20:228–231.

25. Ahmed M, Bjurholm A, Theodorsson E, Schultzberg M, Kreicbergs A. Neuropeptide Y- and vasoactive intestinal polypeptide-like immunoreactivity in adjuvant arthritis: Effects of capsaicin treatment. Neuropeptides 1995;29:33–43.

26. Menkes CJ, Renoux M, Laoussadi S, Mauborgne A, Bruxelle J, Cesselin F. Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 1993;20:714–717.

27. Hernanz A, De Miguel E, Romera N, Perez-Ayala C, Gijon J, Arnalich F. Calcitonin gene-related peptide II, substance P and vasoactive intestinal peptide in plasma and synovial fluid from patients with inflammatory joint disease. Br J Rheumatol 1993;32:31–35.

28. Lundeberg T, Alstergren P, Appelgren A, et al. A model for experimentally induced temporomandibular joint arthritis in rats: Effects of carrageenan on neuropeptide-like immunoreactivity. Neuropeptides 1996;30:37–41.

29. Hukkanen M, Konttinen YT, Rees RG, Santavirta S, Terenghi G, Polak JM. Distribution of nerve endings and sensory neuropeptides in rat synovium, meniscus and bone. Int J Tissue React 1992;14:1–10.

30. Pereira de Silva JA, Carmo-Fonseca J. Peptide containing nerves in human synovium: Immunohistochemical evidence for decreased innervation in rheumatoid arthritis. J Rheumatol 1990;17:1592–1599.

31. Mapp PI, Kidd BL, Merry P. Neuropeptides are found in normal and inflamed human synovium. Br J Rheumatol 1989;28:8.

32. Imai S, Tokunaga Y, Konttinen YT, Maeda T, Hukuda S, Santavirta S. Ultrastructure of the synovial sensory peptidergic fibres is distinctively altered in different phases of adjuvant induced arthritis in rats: Ultramorphological characterisation combined with morphometric and immunohistochemical study for substance P, calcitonin gene related peptide, and protein gene product 9.5. J Rheumatol 1997;24(11):2177–2187.

33. Da Silva JA, Fonseca JE, Graca L, Moita L, Carmo-Fonseca M. Reinnervation of post-arthritic joints in the rat. Clin Exp Rheumatol 1996;14(1):45–51.

34. Yoshida H, Fujita S, Nishida M, Iizuka T. The expression of substance P in human temporomandibular joint (TMJ) samples: An immunohistochemical study. J Oral Rehabil 1999;26(4):338–344.

35. Wyke G. The neurology of joints. Ann R Coll Surg Engl 1967;41:25–50.

36. Polacek P. Receptors of the joints: Their structure, variability and classification. Acta Fac Med Univ Brun 1966;23:1–107.

37. Keller JH, Moffett BC. Nerve endings in the temporomandibular joint of the Rhesus monkey. Anat Rec 1968;160:587–594.

38. Dreessen D, Halata Z, Strasmann T. Sensory innervation of the temporomandibular joint in the mouse. Acta Anat (Basel) 1990;139:154–160.

39. Franks AST. Studies on the innervation of the temporomandibular joint and lateral pterygoid muscle in animals. J Dent Res1965;43(suppl):947–948.

40. Ichikawa H, Wakisaka S, Matsuo S, Akai M. Peptidergic innervation of temporomandibular disk in rat. Experimentia 1989;45:303–304.

41. Kido MA, Kiyoshima T, Kondo T, et al. Distribution of substance P and calcitonin gene-related peptide-like immunoreactive nerve fibres in the rat temporomandibular joint. J Dent Res 1993;72:592–598.

42. Johansson A-S, Isacsson G, Isberg A, Granholm A-C. Distribution of substance P-like immunoreactive nerve fibers in temporomandibular joint soft tissues of monkeys. Scand J Dent Res 1986;94:225–230.

43. Ramieri G, Anselmetti GC, Baracchi F, et al. The innervation of human teeth and gingival epithelium as revealed by means of an antiserum for protein-gene product 9.5 (PGP 9.5). Am J Anat 1990;189:146–154.

44. Morani V, Previgliano V, Schierano GM, Ramieri G. Innervation of the human temporomandibular joint capsule and disc as revealed by immunohistochemistry for neurospecific markers. J Orofac Pain 1994;8:36–41.

45. Schaible HG, Grubb BP. Afferent and spinal mechanisms of joint pain. Pain 1993;55:5–54.

46. Schmid F. On the nerve distribution of the temporomandibular joint capsule. Oral Surg Oral Med Oral Pathol 1969;28:63–66.

47. Widenfalk B, Wiberg M. Origin of sympathetic and sensory innervation of the temporomandibular joint. A retrograde axonal tracing study in the rat. Neurosci Lett 1990;109:30–35.

48. Klineberg I. Structure and function of temporomandibular joint innervation. Ann R Coll Surg Engl 1971;49:268–288.

49. Thilander B. Innervation of the temporomandibular joint capsule in man. Trans R Sch Dent Stockh Umea 1961;7:1–67.

50. Haeuchi Y, Matsumoto K, Ichikawa H, Maeda S. Immunohistochemical demonstration of neuropeptides in the articular disk of the human temporomandibular joint. Cells Tissues Organs 1999;164:205–211.

51. Gulbenkian S, Wharton J, Polak JM. The visualization of cardiovascular innervation in the guinea-pig using an antiserum to protein gene peptide 9.5. J Autonomic Nerv Syst 1987;18:235–247.

52. Hökfelt T, Kellerth JO, Nilsson G, Pernow B. Morphological report for a transmitter role of substance P immuno-histochemical localization in the central nervous system and in some primary sensory neurons. Science 1975;190:889–890.

53. Gibbins IL, Morris JL. Co-existence of neuropeptides in sympathetic, cranial, autonomic and sensory neurons innervating the iris of the guinea-pig. J Autonomic Nerv Syst 1987;21:67–82.

54. Gibson SJ, Polak JM, Bloom SR, et al. Calcitonin generelated peptide immunoreactivity in the spinal cord of men and of eight other species. J Neurosci 1984;14:3101–3111.

55. Kummer W, Gibbins IL, Stefan P, Kapoor V. Catecholamines and catecholamine-synthesizing enzymes in guinea-pig sensory ganglia. Cell Tissue Res 1990;261:595–606.

56. Morris JL, Gibbins IL, Murphy R. Neuropeptide Y–like immunoreactivity is absent from most perivascular noradrenergic axons in a marsupial, the brush-tailed possum. Neurosci Lett 1986;62:31–37.

57. Morris JL, Gibbins IL. Neuronal colocalization of peptides, catecholamines and catecholamine-synthesizing enzymes in the guinea-pig paracervical ganglia. J Neurosci 1987;7:3117–3130.